Skip to main content
Premium Trial:

Request an Annual Quote

Matthew Kalnik, Gary Christianson, Frederick Cook, John Cremmen, Bradley McGill, Shawn McMahon, Heather O’Donnell, Christopher Ostop, Linda Swain, Anthony Warren, Steven Wassersug, Jeffrey Abromovitz, Kevin Mealey, Thomas O’Connor, Walter Schwert, James S

Premium
Nabi Names VP for Business Development and Project Management
 
Matthew Kalnik has been named vice president of business development and project management by Nabi Biopharmaceuticals. He succeeds Joy Barton, who according to Nabi, “left the company to pursue other opportunities.”
 
Kalnik will work with Nabi’s senior management team and pharmaceutical research & development group to accelerate partnership and licensing discussions for the company's NicVAX (Nicotine Conjugate Vaccine) and StaphVAX (Staphylococcus aureus Polysaccharide Conjugate Vaccine) programs.
 
Previously, Kalnik served as executive vice president and head of business development at VistaGen Therapeutics, where he helped advance the company's commercialization efforts. Earlier, he held senior management team positions and led business development efforts at Genaissance Pharmaceuticals, Pharmacia, Pfizer and Daiichi Medical Research. Kalnik also founded Hedgerow Consulting.
 
Kalnik will work from Nabi's Rockville, Md., facility. The company is headquartered in Boca Raton, Fla.
 

 
Biomira Names GSK Site Director as New Chief Operating Officer
 
Gary Christianson has been named to the newly created position of chief operating officer at Edmonton-based Biomira. His duties will include leading manufacturing activities for the Edmonton-based cancer therapeutics developer’s phase 3 vaccine, Stimuvax, as well as technical development and manufacturing of pipeline products.
 
Christianson previously was site director for GlaxoSmithKline's biologics unit in Hamilton, Mont., where he oversaw staffing and planning for a 250-person facility that manufactured a key component of several GSK vaccines. Earlier he held positions at Corixa and RIBI ImmunoChem Research.
 
He received a BSc in mechanical engineering technology from Montana State University. He is a member of numerous professional organizations, including the International Society for Pharmaceutical Engineers and the Parenteral Drug Association.
 

 
Jones Lang LaSalle Names Nine from Boston Region as National Directors
 
Jones Lang LaSalle has named nine professionals from the Boston region as national directors:
 
  • Frederick Cook, a vice president with Jones Lang LaSalle Construction.
  • John Cremmen, a senior vice president in JLL’s leasing group responsible for building, land sales and leasing in Boston.
  • Bradley McGill, senior vice president specializing in representing tenants and landlords in the downtown Boston office market.
  • Shawn McMahon, a senior vice president and senior member of JLL’s Hartford office. He focuses on agency leasing of office buildings, local and regional tenant representation, consulting, and investment dispositions in central Connecticut and western Massachusetts.
  • Heather O’Donnell, a vice president in the investment management group, focusing on asset management and investor relations.
  • Christopher Ostop, a vice president in the Hartford office whose primary responsibilities include agency leasing, local and regional tenant representation, consulting, and investment sales; he is the primary contact for CityPlace I.
  • Linda Swain, a senior vice president who defines and manages the strategic marketing direction for JLL’s New England region.
  • Anthony Warren, a vice president in the development group with responsibilities spanning pre-construction planning through project management.
  • Steven Wassersug, a senior vice president in Jones Lang LaSalle Construction.
 
In other personnel announcements, JLL named five new associate directors: Jeffrey Abromovitz, Kevin Mealey, Thomas O’Connor, Walter Schwert, and James Silva. The company also named five managing directors: William Collins, Philip DeSimone, Scott Jamieson, James Koury, and William Motley.
 

 
CB Richard Ellis/New England Adds to its Downtown Brokerage Team
 
Lauren Phelan Lipscomb has joined CB Richard Ellis/New England in Boston as a vice president on its downtown brokerage team.
 
Previously, Lipscomb was a leasing representative for Boston Properties, where she oversaw the marketing and leasing for 2.6 million square feet of office space in the Prudential Center. During her five-year tenure with Boston Properties, she also participated in the renovation and repositioning of 265 Franklin Street, and was engaged in the marketing and leasing of Cambridge Center.
 
An honors graduate of Georgetown University with a BA in government, Lipscomb is also active in community organizations, including United Way of Massachusetts Bay, Newton Country Day School Facilities Committee, American Ireland Fund, Boys & Girls Club of Boston, Georgetown University Alumni Admissions Program, and Shelter Incorporated. She is a member of the National Association of Office & Industrial Properties, the Commercial Brokers Association, and New England Women in Real Estate.
 

 
CU-Boulder Professor, a Biotech Pioneer, Honored With National Medal of Science
Marvin Caruthers, distinguished professor of chemistry and biochemistry at the University of Colorado at Boulder, will receive the nation's highest accolade for scientific achievement, the National Medal of Science, during a July 27 White House ceremony.
 
Caruthers is being recognized for a lifetime of accomplishments, including his pioneering research in nucleic acid chemistry that resulted in new methods for the chemical synthesis of DNA and RNA. He co-founded Applied Biosystems, which marketed "gene machines" based on the DNA synthesis methods developed in Caruthers' laboratory, and drug developer Amgen. Caruthers remains active in Boulder’s biotechnology industry as a consultant for Boulder Ventures.
 
He was one of eight 2006 National Medal of Science award winners and five 2006 National Medal of Technology winners announced by President Bush. A 34-year faculty member of UC-Boulder, Caruthers serves on the board of directors for Array Biopharma and Barofold, and on the scientific advisory board for Alphasniffer, Agilent, and Nanosphere. He is also a member of the American Academy of Arts and Sciences and the National Academy of Sciences.
Caruthers graduated from Iowa State University and received his doctorate at Northwestern University.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.